ReviewNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2020

The Pharmacogenetics of Rituximab: Potential Implications for Anti-CD20 Therapies in Multiple Sclerosis.

Michael Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.